We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+0.05%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$3.55B
AUM Growth
+$59.4M
Cap. Flow
+$77M
Cap. Flow %
2.17%
Top 10 Hldgs %
49.57%
Holding
665
New
156
Increased
155
Reduced
111
Closed
128

Top Buys

Rank Stock Value
1
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$138M
2
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
+$131M
3
EDR
Endeavor Group Holdings, Inc.
EDR
+$127M
4
MRO
Marathon Oil Corporation
MRO
+$123M
5
CHX
ChampionX
CHX
+$98.3M

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$638M
2
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$51.2M
3
DFS
Discover Financial Services
DFS
+$45.1M
4
SCRM
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
+$18.4M
5
NSC icon
Norfolk Southern
NSC
+$17.7M

Sector Composition

Rank Sector Weight
1 Energy 26.53%
2 Technology 21.03%
3 Healthcare 14.68%
4 Industrials 8.19%
5 Materials 6.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRNA
626
DELISTED
Verona Pharma
VRNA
– –
-36,305
Closed -$530K
VTYX
627
DELISTED
Ventyx Biosciences
VTYX
– –
-134,000
Closed -$737K
W icon
628
Wayfair
W
$14.6B
– –
-4,000
Closed -$272K
WIX icon
629
WIX.com
WIX
$2.52B
– –
-2,500
Closed -$344K
XBI icon
630
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.3B
– –
-90,000
Closed -$232K
XENE icon
631
Xenon Pharmaceuticals
XENE
$6.12B
– –
-7,987
Closed -$344K
ZS icon
632
Zscaler
ZS
$27.3B
– –
-20,000
Closed -$3.85M
ZYME icon
633
Zymeworks
ZYME
$1.73B
– –
-54,457
Closed -$573K
AVBP icon
634
ArriVent BioPharma
AVBP
$1.44B
– –
-26,181
Closed -$468K
BOLD
635
Boundless Bio
BOLD
$65M
– –
-41,650
Closed -$594K
PHYT
636
DELISTED
Pyrophyte Acquisition Corp.
PHYT
– –
-159,438
Closed -$1.77M
SILK
637
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
– –
-90,556
Closed -$1.66M
AIRC
638
DELISTED
Apartment Income REIT Corp.
AIRC
– –
-46,425
Closed -$1.51M
COOLW
639
DELISTED
Corner Growth Acquisition Corp. Warrant
COOLW
– –
-75,251
Closed -$13.2K
APCA
640
DELISTED
AP Acquisition Corp
APCA
– –
-187,581
Closed -$2.12M
DCPH
641
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
– –
-151,796
Closed -$2.39M
ERF
642
DELISTED
Enerplus Corporation
ERF
– –
-810,000
Closed -$15.9M
PUCKW
643
DELISTED
Goal Acquisitions Corp. Warrant
PUCKW
– –
-283,281
Closed -$3.46K
OSI
644
DELISTED
Osiris Acquisition Corp.
OSI
– –
-55,585
Closed -$589K
SP
645
DELISTED
SP Plus Corporation
SP
– –
-298,558
Closed -$15.6M
SCRM
646
DELISTED
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
– –
-1,719,492
Closed -$18.4M
CONXW
647
DELISTED
CONX Corp. Warrant
CONXW
– –
-316,890
Closed -$55.5K
PXD
648
DELISTED
Pioneer Natural Resource Co.
PXD
– –
-2,431,644
Closed -$638M
TCN
649
DELISTED
Tricon Residential Inc.
TCN
– –
-1,000,000
Closed -$11.2M
DSAQ
650
DELISTED
Direct Selling Acquisition Corp.
DSAQ
– –
-160,685
Closed -$1.78M
23 24 25
26
27

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return

UBS O'Connor's Q2 2024 Portfolio in Review

As of Q2 2024, UBS O'Connor held 665 positions worth $3.55B, up 1.7% from $3.49B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

UBS O'Connor's Q2 2024 filing shows 156 new, 155 increased, 111 reduced and 128 closed positions. Its largest new stake was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M. The largest sale was Pioneer Natural Resource Co., an estimated $638M.

By sector, the portfolio is most concentrated in Energy at 27% of assets, down from 34% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q2 2024 buy was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M.
  • UBS O'Connor added most to HashiCorp, Inc. Class A Common Stock in Q2 2024, an estimated $138M increase.
  • UBS O'Connor's biggest Q2 2024 reduction was Cerevel Therapeutics Holdings, Inc. Common Stock, cutting an estimated $51.2M.
  • UBS O'Connor fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $638M.
  • UBS O'Connor's ten largest holdings make up 50% of its $3.55B portfolio in Q2 2024.
  • UBS O'Connor opened 156 new positions and closed 128 in Q2 2024.
  • UBS O'Connor's portfolio value rose 1.7% quarter-over-quarter to $3.55B.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.